"Shock, Septic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include, but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Descriptor ID |
D012772
|
| MeSH Number(s) |
C01.539.757.800 C23.550.470.790.500.800 C23.550.835.900.712
|
| Concept/Terms |
Shock, Toxic- Shock, Toxic
- Toxic Shock
- Toxic Shock Syndrome
- Shock Syndrome, Toxic
- Shock Syndromes, Toxic
- Syndrome, Toxic Shock
- Syndromes, Toxic Shock
- Toxic Shock Syndromes
|
Below are MeSH descriptors whose meaning is more general than "Shock, Septic".
Below are MeSH descriptors whose meaning is more specific than "Shock, Septic".
This graph shows the total number of publications written about "Shock, Septic" by people in this website by year, and whether "Shock, Septic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 3 | 0 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 4 | 8 |
| 2015 | 3 | 1 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 5 | 0 | 5 |
| 2019 | 4 | 0 | 4 |
| 2020 | 7 | 0 | 7 |
| 2021 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Shock, Septic" by people in Profiles.
-
Tomlinson G, Al-Khafaji A, Conrad SA, Factora FNF, Foster DM, Galphin C, Gunnerson KJ, Khan S, Kohli-Seth R, McCarthy P, Meena NK, Pearl RG, Rachoin JS, Rains R, Seneff M, Tidswell M, Walker PM, Kellum JA. Bayesian methods: a potential path forward for sepsis trials. Crit Care. 2023 11 08; 27(1):432.
-
Bosch NA, Teja B, Law AC, Wunsch H, Walkey AJ. Arterial Pressure Response to an Increase in Norepinephrine Varies Depending on the Baseline Norepinephrine Dose in Patients With Septic Shock. Chest. 2023 11; 164(5):1228-1231.
-
Bosch NA, Teja B, Law AC, Pang B, Jafarzadeh SR, Walkey AJ. Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone Among Patients With Septic Shock. JAMA Intern Med. 2023 05 01; 183(5):451-459.
-
Teja B, Bosch NA, Wijeysundera DN, Wijeysundera HC, Saskin R, Hill AD, Stelfox HT, Walkey AJ, Wunsch H. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study. Ann Am Thorac Soc. 2022 10; 19(10):1713-1721.
-
Boccio E, Haimovich A, Jacob V, Zhao X, Wira CR, Venkatesh A, Belsky J. Establishment of SEP-1 national practice guidelines does not impact fluid administration for septic shock patients. Am J Emerg Med. 2022 12; 62:19-24.
-
Teja B, Bosch NA, Walkey AJ. How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock. Chest. 2023 03; 163(3):567-574.
-
Law AC, Bosch NA, Peterson D, Walkey AJ. Comparison of Heart Rate After Phenylephrine vs?Norepinephrine Initiation in Patients With Septic Shock and Atrial Fibrillation. Chest. 2022 10; 162(4):796-803.
-
Bosch NA, Teja B, Wunsch H, Walkey AJ. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States. Ann Am Thorac Soc. 2021 12; 18(12):2049-2057.
-
Mir T, Uddin M, Qureshi WT, Abohashem S, Alqalyoobi S, Sheikh M, Soubani A, Saydain G, Albertson TE. ST-Elevation Myocardial Infarction Among Septic Shock and Coronary Interventions: A National Emergency Database Study. J Intensive Care Med. 2022 Aug; 37(8):1094-1100.
-
Boccio E, Haimovich AD, Jacob V, Maciejewski KR, Wira CR, Belsky J. Sepsis Fluid Metric Compliance and its Impact on Outcomes of Patients with Congestive Heart Failure, End-Stage Renal Disease or Obesity. J Emerg Med. 2021 11; 61(5):466-480.